2019
DOI: 10.1093/ajhp/zxy089
|View full text |Cite
|
Sign up to set email alerts
|

The opioid crisis: Origins, trends, policies, and the roles of pharmacists

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
67
0
3

Year Published

2019
2019
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 101 publications
(84 citation statements)
references
References 62 publications
2
67
0
3
Order By: Relevance
“…The initiative “Pain as the Fifth Vital Sign” lowered the threshold for medical treatment of pain to any pain score >0. This change has been suggested to be one of the important drivers of the current opioid epidemic which has claimed hundreds of thousands of lives . However, it is important to recognize that the Pain as the Fifth Vital Sign initiative was motivated by compassion for patients and it was events happening in parallel where opioid medicines were misleadingly marketed to doctors, patients and patient advocacy groups that enabled overdefinition to cause so much harm.…”
Section: Overdefinitionmentioning
confidence: 99%
“…The initiative “Pain as the Fifth Vital Sign” lowered the threshold for medical treatment of pain to any pain score >0. This change has been suggested to be one of the important drivers of the current opioid epidemic which has claimed hundreds of thousands of lives . However, it is important to recognize that the Pain as the Fifth Vital Sign initiative was motivated by compassion for patients and it was events happening in parallel where opioid medicines were misleadingly marketed to doctors, patients and patient advocacy groups that enabled overdefinition to cause so much harm.…”
Section: Overdefinitionmentioning
confidence: 99%
“…Research on the opioid crisis identifies economic deprivation, overprescribing, and inadequate treatment access as root causes. [51][52][53] This study has shown that lack of relative visibility of critical EMS agency interventions, beyond naloxone administration, could also be a contributing factor. There are also signification gaps in presentation of the outcomes of these programs which could limit replication across other communities.…”
Section: Discussionmentioning
confidence: 88%
“…Among other recommendations, the CDC guideline also suggests prescribing the lowest effective dose of opioids, conducting periodic evaluation of the benefits and harms of opioid therapy in a given patient, and periodically reviewing state prescription drugmonitoring systems to review patients' history of controlled substance prescriptions to assist in decision-making regarding opioid prescription/management [47,48]. Additional recommended strategies include educating and counseling patients concerning appropriate pain management, screening patients for risk of opioid abuse using instruments such as the Opioid Risk Tool, and referring patients to addiction treatment specialists as needed, among other strategies [49]. RTRs, particularly those who use high levels of opioids chronically, would likely also benefit from education about the use of opioid overdose reversal agents such as naloxone [49].…”
Section: Discussionmentioning
confidence: 99%
“…Additional recommended strategies include educating and counseling patients concerning appropriate pain management, screening patients for risk of opioid abuse using instruments such as the Opioid Risk Tool, and referring patients to addiction treatment specialists as needed, among other strategies [49]. RTRs, particularly those who use high levels of opioids chronically, would likely also benefit from education about the use of opioid overdose reversal agents such as naloxone [49].…”
Section: Discussionmentioning
confidence: 99%